Your browser doesn't support javascript.
loading
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
Harris, Patrick N A; Peleg, Anton Y; Iredell, Jon; Ingram, Paul R; Miyakis, Spiros; Stewardson, Andrew J; Rogers, Benjamin A; McBryde, Emma S; Roberts, Jason A; Lipman, Jeff; Athan, Eugene; Paul, Sanjoy K; Baker, Peter; Harris-Brown, Tiffany; Paterson, David L.
Affiliation
  • Harris PN; University of Queensland Centre for Clinical Research, Building 71/918 Royal Brisbane & Women's Hospital Campus, Herston, 4029, Brisbane, QLD, Australia. p.harris@uq.edu.au.
  • Peleg AY; Department of Infectious Diseases, The Alfred Hospital, Melbourne, VIC, Australia. anton.peleg@monash.edu.
  • Iredell J; Westmead Millenium Institute for Medical Research, Westmead Hospital, Sydney, NSW, Australia. jon.iredell@swahs.health.nsw.gov.au.
  • Ingram PR; Department of Microbiology and Infectious Diseases, Royal Perth Hospital, Perth, WA, Australia. paul.ingram@health.wa.gov.au.
  • Miyakis S; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, WA, Australia. paul.ingram@health.wa.gov.au.
  • Stewardson AJ; Department of Infectious Diseases, School of Medicine, University of Wollongong and The Wollongong Hospital, Wollongong, NSW, Australia. spiros_miyakis@uow.edu.au.
  • Rogers BA; Department of Infectious Diseases, Austin Health, Melbourne, VIC, Australia. andrew.stewardson@gmail.com.
  • McBryde ES; Monash Infectious Disease, Monash Health, Clayton, VIC, Australia. b.rogers1@uq.edu.au.
  • Roberts JA; Victorian Infectious Diseases Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia. emma.mcbryde@burnet.edu.au.
  • Lipman J; Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.
  • Athan E; Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, QLD, Australia. j.lipman@uq.edu.au.
  • Paul SK; Department of Infectious Disease, Barwon Health, Deakin University, Geelong, VIC, Australia. eugene@barwonhealth.org.au.
  • Baker P; Clinical Trials & Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. Sanjoy.Paul@qimrberghofer.edu.au.
  • Harris-Brown T; Queensland Clinical Trials and Biostatistics Centre, University of Queensland, Brisbane, QLD, Australia. p.baker1@uq.edu.au.
  • Paterson DL; University of Queensland Centre for Clinical Research, Building 71/918 Royal Brisbane & Women's Hospital Campus, Herston, 4029, Brisbane, QLD, Australia. t.brown3@uq.edu.au.
Trials ; 16: 24, 2015 Jan 27.
Article in En | MEDLINE | ID: mdl-25623485
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ceftriaxone / Klebsiella Infections / Thienamycins / Clinical Protocols / Bacteremia / Penicillanic Acid / Escherichia coli Infections / Anti-Bacterial Agents Type of study: Clinical_trials / Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2015 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ceftriaxone / Klebsiella Infections / Thienamycins / Clinical Protocols / Bacteremia / Penicillanic Acid / Escherichia coli Infections / Anti-Bacterial Agents Type of study: Clinical_trials / Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2015 Type: Article Affiliation country: Australia